281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

Year: 2017

New White Paper Released – Stability of Plasmid DNA Products

December 12, 2017

Stability of Plasmid DNA Products: A Review of the Data For any pharmaceutical product, an important consideration is the handling and environmental conditions that the material may experience from the time it is manufactured until final dosing of a patient. Plasmid DNA is generally recognized to have exceptional stability compared to other biologics such as… Read More »

Filed Under: Blog, Media, Publications

New White Paper Released – Calculating your DNA plasmid needs.

November 2, 2017

Calculating the amount of plasmid DNA needed for a  clinical trial may seem straightforward – simply multiply the dose by the number of doses to be administered.  However, there are many factors to consider, and the required production scale may be several times the amount needed for clinical dosing. This white paper walks through one case study to illustrate how much plasmid… Read More »

Filed Under: Blog

GeneOne Life Science Receives Approval for Phase I/IIa MERS-CoV Vaccine Trial in Korea

September 15, 2017

GeneOne Life Science Receives Approval of IND by the Korean Ministry of Food and Drug Safety (KMFDS) of MERS-CoV Plasmid DNA vaccine, GLS-5300, for a Phase I/IIa Clinical Trial in Korea SEOUL, KOREA (PRWEB) September 17, 2017 GeneOne Life Science, Inc. announces that it has received approval from the South Korean Ministry of Food and Drug… Read More »

Filed Under: Media, News

Special Message Regarding Hurricane Harvey

August 31, 2017

VGXI has reopened and we are getting back to normal operations. Our thoughts are with all those who have been affected by Hurricane Harvey, including our employees, their families, and all our neighbors in the area. For any who would like to contribute to the recovery effort, please consider a donation to one of the… Read More »

Filed Under: Media, News

Hurricane Harvey Update!

August 27, 2017

Update: VGXI will open for business on Thursday, August 31, 2017. To ensure the safety of our employees and their families, VGXI closed from Monday through Wednesday, August 28th – 30th, 2017. Please stay safe and check back on our website or facebook page for updates.

Filed Under: Media, News

Meet VGXI at the 2017 ISV Congress

July 26, 2017

Heading to Paris in October? Meet with representatives from VGXI and learn more about our products and services! We also welcome requests for partnering meetings during the conference. Contact Us today to make arrangements.  2017 International Society of Vaccines Annual Congress October 5 – 7, 2017 Institute Pasteur Paris, France

Filed Under: Events, Media, News

Come See VGXI at the 2017 BIO International Convention

June 1, 2017

Come by Booth #1025 to meet us and find out more about VGXI’s products and services! We also welcome requests for partnering meetings during the conference. Biotechnology Industry Organization International Convention June 19-20, 2017 San Diego Convention Center San Diego, CA  

Filed Under: Uncategorized

View our poster presented at the ASGTC 2017 Annual Meeting

May 15, 2017

Did you miss us at ASGCT? Download our poster at the link below: Novel Method for RNA Quantification and Exclusion from Plasmid DNA Vector Purification Process Stream Presented on Thursday, May 11, 2017 from 5:15 pm – 7:15 pm Session Information: Vector and Cell Engineering and Manufacturing Location: Exhibit Hall C & B South Abstract #484… Read More »

Filed Under: Events, Media

Meet us and view our poster at the ASGTC 2017 Annual Meeting

May 1, 2017

VGXI will be attending the 2017 ASGTC Annual Meeting. Come view our poster presentation: Novel Method for RNA Quantification and Exclusion from Plasmid DNA Vector Purification Process Stream To be presented on Thursday, May 11, 2017 from 5:15 pm – 7:15 pm Session Information: Vector and Cell Engineering and Manufacturing Location: Exhibit Hall C & B South… Read More »

Filed Under: Uncategorized

VGXI Wins 2017 Vaccine Industry Excellence (ViE) Award for Best Contract Manufacturing Organization

April 11, 2017

VGXI announced that on April 10th, 2017 the corporation won the award for Best Production / Process Development at the 10th Annual ViE Awards Ceremony held at the 2017 World Vaccine Congress in Washington, D.C.

Filed Under: Events, Media, News

Meet VGXI at the 2017 World Vaccine Congress

January 16, 2017

WVC is the ultimate meeting place for vaccine experts worldwide. 8 Conferences. 3 Days. 1 Event! April 10 – 12th, 2017 Grand Hyatt, Washington D.C. Join us and over 700 senior decision makers in Washington for three in-depth days of discussion and debate! WVC hosts over 150 sessions with leading experts speaking on issues for… Read More »

Filed Under: Uncategorized

Archives

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font
Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy